Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans
about
Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux diseaseRole of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.Transient lower oesophageal sphincter relaxations--a pharmacological target for gastro-oesophageal reflux disease?Review article: gastro-oesophageal reflux disease--pathophysiological issues of clinical relevance.New developments in the pathophysiology of gastro-oesophageal reflux disease (GERD): implications for patient management.Relationship between motor function of the proximal stomach and transient lower oesophageal sphincter relaxation after morphine.Review article: the pathophysiology of gastro-oesophageal reflux disease - oesophageal manifestations.Pharmacological targets in gastro-oesophageal reflux disease.Review article: the clinical relevance of transient lower oesophageal sphincter relaxations in gastro-oesophageal reflux disease.Effect of low and high fat meals on lower esophageal sphincter motility and gastroesophageal reflux in healthy subjects.Neuro-regulation of lower esophageal sphincter function as treatment for gastroesophageal reflux disease.Beyond acid suppression: new pharmacologic approaches for treatment of GERD.The effect of cholecystokinin antagonism on postprandial lower oesophageal sphincter function in asymptomatic volunteers and patients with reflux disease.Synergy between low-dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal-induced heartburn.Cisapride inhibits meal-stimulated gastric acid secretion and post-prandial gastric acidity in subjects with gastro-oesophageal reflux disease.The effect of glucagon-induced gastric relaxation on TLOSR frequency.Differential effects of baclofen on lower oesophageal sphincter pressure and proximal gastric motility in humans.Effect of non-selective gamma-aminobutyric acid receptor stimulation on motor function of the lower oesophageal sphincter and gastro-oesophageal reflux in healthy human subjects.The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis.SR 48692, a specific neurotensin receptor antagonist, has no effect on oesophageal motility in humans.Postprandial water intake inhibits gastric antral motility with increase of cholecystokinin in humans.Does impaired gallbladder function contribute to the development of Barrett's esophagus and esophageal adenocarcinoma?Prospective study of the effect of laparoscopic Nissen fundoplication on reflux mechanisms.Motor and sensory function of the proximal stomach in reflux disease and after laparoscopic Nissen fundoplication.
P2860
Q28344338-69979158-5039-4A5C-89BA-4F30F02A2B04Q30487910-15F96122-BA93-41A1-A23B-4795389A0E04Q34539246-93E0ED58-16C6-4B02-AC4B-2926CDC19C38Q34669257-F137C2E4-7CA0-4C00-B28B-DB620812E55FQ35145028-4E7CB315-032D-4C51-9A17-7FBC8F1315E4Q35596770-608491E1-22DC-4234-B337-65BAB7FC41D0Q35939790-DDA33DF1-2271-4C25-8E82-D43293365DA7Q36346427-BBC06120-9587-4220-90B9-102074A210BEQ37827182-233E7F1A-9523-442A-B254-BC1A08FA37A0Q39439261-4DA9C32E-EC6C-414B-B00F-7D8ADC488DD6Q43066275-B7A6203C-BD18-46EE-8640-9DFC7D46B4D4Q43082855-DBD5FA57-FC20-4777-A3D0-C5049F415E12Q43734559-6A6C4813-894F-4993-ABA3-1A2E24F28A50Q43734561-1A1DAC68-A1C4-4BCC-BFD7-BBC9AB2EAE1DQ44148256-5E9A464F-D000-4B8D-AA55-D88D9FD398C2Q44316635-44A8F2DB-86CD-40D7-A59A-1493814E7FE9Q44517217-74845DBE-5F19-4DC6-B702-2369FF8F14B7Q44596959-0105FF4B-D81D-4DC4-B975-AA3FDB2B2807Q44654798-8EAB5256-45E8-4A75-8AF7-C4175591977FQ44841398-DC3E6568-D853-4A1F-86E7-AA1D7C97B2A6Q46787444-ABF7A875-3C83-403A-8C9F-EB8CFC7A7082Q51375080-1041278B-A336-4A7B-9C89-A38659DB63BCQ51546410-6D1DB1B2-0C2D-4708-9FB1-A5D2920A96D9Q51562980-8A642F4D-94FA-418B-A1C7-361CDD2E42A3
P2860
Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Cholecystokinin in transient l ...... o gastric distension in humans
@ast
Cholecystokinin in transient l ...... o gastric distension in humans
@en
type
label
Cholecystokinin in transient l ...... o gastric distension in humans
@ast
Cholecystokinin in transient l ...... o gastric distension in humans
@en
prefLabel
Cholecystokinin in transient l ...... o gastric distension in humans
@ast
Cholecystokinin in transient l ...... o gastric distension in humans
@en
P2093
P2860
P356
P1433
P1476
Cholecystokinin in transient l ...... o gastric distension in humans
@en
P2093
P2860
P304
P356
10.1136/GUT.40.5.575
P407
P577
1997-05-01T00:00:00Z